Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Feb 2018 for Sucampo Pharmaceuticals, Inc., €75k. Read the official filing
Filing timeline
BuySaleJones W. Bryan
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jones W. Bryan: trading record in brief
Jones W. Bryan is a declared insider of Sucampo Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 4 August 2017 and 13 February 2018, the trades on record add up to 3 filings.
No open-market sale appears; the market trades are 1 purchase worth €42k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant.
The latest filing, published on 13 February 2018, reports a transaction of €75k in Sucampo Pharmaceuticals, Inc. The last purchase on record was published on 7 August 2017, which is 3,362 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jones W. Bryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
5,139 shares@ US$18.0062.2% of flowCommon Stock, Class ASEC:0001171843-18-001101:0
439 shares@ US$10.243.1% of flowCommon Stock, Class A (ESPP)SEC:0001171843-18-000344:0
4,700 shares@ US$10.6034.7% of flowCommon Stock, Class ASEC:0001171843-17-004784:0
Canonical exit: 2 Nov 2017 (T+90)
3 of 3 declarations
